Decision Makers

Viruses and bacteria are not the only ones to spread during an epidemic. Rumours and misinformation can do that too, eventually leading to the constitution of a parallel information system that could undermine the efficacy of the institutional communication. Similar situations often arise in case of contested knowledge or when only few highly technical experts are left dealing with scientific information.

Monday, October 12, 2015 (All day)

The Health Department of the European Commission will organise a conference for Member States and partners on lessons to be learned from the Ebola epidemic. The event is organised in close collaboration with the Luxembourg Presidency of the Council and will take place in Mondorf-les-Bains from 12 to 14 October 2015. There will be four sessions, each of them focusing on a specific topic:

Many experts talk about pandemics and about the importance of preparedness but, based on the previous experience with the 2009 A(H1N1) swine flu, the issue of what a pandemic is and when it has to be declared is still under debate.

The first meeting of the Asset High Level Policy Forum was held in Bruxelles on March 12.  The Forum was intended to bring together selected European policy-makers at regional, national and EU levels, key decision makers in health agencies, the pharmaceutical industry, and civil society organisations, in a unique and interactive dialogue to promote on-going reflection on EU strategic priorities about pandemics.

Monday, March 30, 2015 (All day)

The European Centre for Disease Prevention and Control (ECDC) has decided to hold a two-days conference in Riga (Latvia) with ministers and high level representatives from the Ministries of Health, Social Affairs and Finance of the European Union, European Economic Area and Eastern Partnership Countries as well as high representatives of the European Commission, members of the European Parliament, representatives of international institu

Tuesday, March 24, 2015 (All day)

World TB Day, on March 24th each year, is aimed at building public awareness about tuberculosis, a disease still causing nearly one-and-a-half million deaths each year, mostly in developing countries.

The debate over measles vaccine is underway in many countries and, in some cases, the discussion came to court. It happened, for instance, in Italy in 2012, when a judge recognized the right to compensation (required by Italian law) for the family of a child vaccinated in 2002 with the trivalent vaccine MPR (measles-mumps-rubella) who were later diagnosed with autism. During the debate, the consultant of the family presented the research of the English physician Andrew Wakefield.

Recognize and respect fear. This is one of the main lessons Ron Klain claims to have learned by his efforts against Ebola. Klain has recently served as the first White House Ebola Response Coordinator, also known as the Ebola Czar. From such a high position, he got a close and deep insight into the dramatic threat to global health represented by the West Africa outbreak.

The recent cases of measles outbreaks in US and Europe reignited the debate on vaccines, the science behind them and the conflict between the right to individual freedom and the state intervention. Amongst the several factors that contribute to the decrease of vaccination coverage – especially in some groups – vaccine hesitancy is one of particular interest, which should require much greater attention from public health and epidemiology, medical sociology, anthropology, and the behavioural, economic and political sciences.

One of the ASSET’s purposes is to develop its approach on different levels, from the global to the local one. This will include both the analysis of specific experiences and the production of new initiatives. According to this aim, the Bulgarian National Center of Infectious and Parasitic Diseases (NCIPD) has just released the Local Communication Plan for Bulgaria, which is a complement of the Communication Strategy of the ASSET project.

Pages

Subscribe to Decision Makers

MMLAP and other EU Projects

Health system analysis to support capacity development in response to the threat of pandemic influenza in Asia
Making society an active participant in water adaptation to global change
Public Participation in Developing a Common Framework for Assessment and Management of Sustainable Innovation
Engaging all of Europe in shaping a desirable and sustainable future
Expect the unexpected and know how to respond
Driving innovation in crisis management for European resilience
Effective communication in outbreak management: development of an evidence-based tool for Europe
Solutions to improve CBRNe resilience
Network for Communicable Disease Control in Southern Europe and Mediterranean Countries
Developing the framework for an epidemic forecast infrastructure
Strengthening of the national surveillance system for communicable diseases
Surveillance of vaccine preventable hepatitis
European monitoring of excess mortality for public health action
European network for highly infectious disease
Dedicated surveillance network for surveillance and control of vaccine preventable diseases in the EU
Modelling the spread of pandemic influenza and strategies for its containment and mitigation
Cost-effectiveness assessment of european influenza human pandemic alert and response strategies
Bridging the gap between science, stakeholders and policy makers
Promotion of immunization for health professionals in Europe
Towards inclusive research programming for sustainable food innovations
Addressing chronic diseases and healthy ageing across the life cycle
Medical ecosystem – personalized event-based surveillance
Studying the many and varied economic, social, legal and ethical aspects of the recent developments on the Internet, and their consequences for the individual and society at large
Get involved in the responsible marine research and innovation
Knowledge-based policy-making on issues involving science, technology and innovation, mainly based upon the practices in Parliamentary Technology Assessment
Assessment of the current pandemic preparedness and response tools, systems and practice at national, EU and global level in priority areas
Analysis of innovative public engagement tools and instruments for dynamic governance in the field of Science in Society
Public Engagement with Research And Research Engagement with Society
Computing Veracity – the Fourth Challenge of Big Data
Providing infrastructure, co-ordination and integration of existing clinical research networks on epidemics and pandemics
Promote vaccinations among migrant population in Europe
Creating mechanisms for effectively tackling the scientific and technology related challenges faced by society
Improve the quality of indoor air, keeping it free from radon
Improving respect of ethics principles and laws in research and innovation, in line with the evolution of technologies and societal concerns
Investigating how cities in the West securitise against global pandemics
Creating a structured dialogue and mutual learning with citizens and urban actors by setting up National Networks in 10 countries across Europe
Identifying how children can be change agents in the Science and Society relationship
Establishing an open dialogue between stakeholders concerning synthetic biology’s potential benefits and risks
Transparent communication in Epidemics: Learning Lessons from experience, delivering effective Messages, providing Evidence